Advanced search    

Search: authors:"John Edelsberg"

12 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Cost-effectiveness of an autoantibody test (EarlyCDT-Lung) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules

publish, or preparation of the manuscript. The specific roles of all authors are articulated in the `author contributions' section. Competing interests: Mark Atwood, John Edelsberg, and Derek Weycker are ... ) Author Contributions Conceptualization: John Edelsberg, Derek Weycker, Geoffrey Hamilton-Fairley, James R. Jett. Data curation: Mark Atwood, Geoffrey Hamilton-Fairley, James R. Jett. 11 / 14 Formal

Rates and costs of invasive pneumococcal disease and pneumonia in persons with underlying medical conditions

disease; IRR: incidence rate ratio; NDC: National Drug Code; NYHA: New York Heart Association; PNE: pneumonia; US: United States. Competing interests Derek Weycker and John Edelsberg are employees of PAI

Risk and consequences of chemotherapy-induced neutropenic complications in patients receiving daily filgrastim: the importance of duration of prophylaxis

Inc. (PAI). Derek Weycker, John Edelsberg, and Alex Kartashov are employed by Policy Analysis Inc. (PAI). Rich Barron and Jason Legg are employed by Amgen Inc. Andrew Glass is employed by the Center for ... financial/other relationships Derek Weycker, John Edelsberg, and Alex Kartashov are employed by Policy Analysis Inc. (PAI). Rich Barron and Jason Legg are employed by Amgen Inc. Andrew Glass is employed by

Risk of Pneumococcal Disease in Children With Chronic Medical Conditions in the Era of Pneumococcal Conjugate Vaccine

Background. In the current era of universal immunization of young children with pneumococcal conjugate vaccine, it is unclear whether the high risk ratios for pneumococcal disease previously attributed to specified chronic conditions have persisted. In addition, further analysis of pneumococcal disease risk may clarify whether certain chronic conditions that currently are not...

Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study

of this manuscript. ST and MM are employees of Pfizer, Inc. Acknowledgements Simon Teal and Marko Mychaskiw are full-time employees of Pfizer Inc. The analyses were conducted by Ariel Berger, John ... Edelsberg, and Gerry Oster, employees of Policy Analysis Inc (PAI). Sophia Zilber, also an employee of PAI, assisted with the statistical programming required for the conduct of this study. All PAI employees

Technical evaluation of methods for identifying chemotherapy-induced febrile neutropenia in healthcare claims databases

Relationships. Derek Weycker, Oleg Sofrygin, Kim Seefeld, and John Edelsberg are employed by PAI. Robert Deeter and Jason Legg are employed by Amgen Inc. and own Amgen stock. Authors contributions Authorship was

Change in healthcare utilization and costs following initiation of benzodiazepine therapy for long-term treatment of generalized anxiety disorder: a retrospective cohort study

Ariel Berger John Edelsberg Michael Treglia Jose Ma J Alvir Gerry Oster Background: Selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and benzodiazepine

Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study

Background Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders (PNDs) who are under the care of general practitioners (GPs) in the UK are not well understood. Methods Using a large electronic UK database, we identified all adults (age ≥ 18 years) with any GP encounters between 1 January 2006 - 31 December 2006 at which a...

Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: A retrospective cohort study

study Ariel Berger 0 John Edelsberg 0 Kafi N Sanders Jose Ma J Alvir Marko A Mychaskiw Gerry Oster 0 0 Policy Analysis Inc. (PAI) , Four Davis Court, Brookline, Massachusetts 02445 , USA Background ... employees of Pfizer Inc. The analyses were conducted by Ariel Berger, John Edelsberg, and Gerry Oster, employees of Policy Analysis Inc (PAI). Fang Zhang is also an employee of PAI and provided assistance

Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study

undertaken, Vamsi Bollu, Jose Alvir, Ashish Dugar, and Ashish Joshi were employees of Pfizer Inc. The analyses were conducted by Ariel Berger, John Edelsberg, and Gerry Oster, all of whom are employees of

Magnitude of potentially inappropriate prescribing in Germany among older patients with generalized anxiety disorder

coauthors of this manuscript; they were involved with the design of the study, data analysis and interpretation, manuscript preparation, and publication decisions. Ariel Berger, M.P.H., John Edelsberg, M.D

Response to Lamotte et al.

higher cost-effectiveness ratios (i.e., they would have found orlistat to be substantially less cost-effective). JOHN EDELSBERG, MD, MPH DEREK WEYCKER, PHD GERRY OSTER, PHD From Policy Analysis Inc